174 related articles for article (PubMed ID: 29665413)
1. Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.
Zhang X; Men T; Liu H; Li X; Wang J; Lv J
Transpl Immunol; 2018 Aug; 49():39-42. PubMed ID: 29665413
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism.
Liang S; Zhu X; Cai R; Yan B; Liang W; Cai M; Yang P
Transplant Proc; 2023 Dec; 55(10):2398-2402. PubMed ID: 37891021
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Matsuura S; Saito M; Tada H; Suzuki T; Habuchi T
Transplantation; 2005 Nov; 80(10):1419-24. PubMed ID: 16340785
[TBL] [Abstract][Full Text] [Related]
6. Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
Oetting WS; Schladt DP; Guan W; Miller MB; Remmel RP; Dorr C; Sanghavi K; Mannon RB; Herrera B; Matas AJ; Salomon DR; Kwok PY; Keating BJ; Israni AK; Jacobson PA;
Am J Transplant; 2016 Feb; 16(2):574-82. PubMed ID: 26485092
[TBL] [Abstract][Full Text] [Related]
7. Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients.
Liu J; Ouyang Y; Chen D; Yao B; Lin D; Li Z; Zang Y; Liu H; Fu X
Int Immunopharmacol; 2018 Apr; 57():18-24. PubMed ID: 29454235
[TBL] [Abstract][Full Text] [Related]
8. Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
Elens L; Capron A; van Schaik RH; De Meyer M; De Pauw L; Eddour DC; Latinne D; Wallemacq P; Mourad M; Haufroid V
Ther Drug Monit; 2013 Oct; 35(5):608-16. PubMed ID: 24052064
[TBL] [Abstract][Full Text] [Related]
9. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
[TBL] [Abstract][Full Text] [Related]
10. CCL2 gene polymorphism is associated with post-transplant diabetes mellitus.
Dabrowska-Zamojcin E; Romanowski M; Dziedziejko V; Maciejewska-Karlowska A; Sawczuk M; Safranow K; Domanski L; Pawlik A
Int Immunopharmacol; 2016 Mar; 32():62-65. PubMed ID: 26802601
[TBL] [Abstract][Full Text] [Related]
11. Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation.
Ro H; Min SI; Yang J; Moon KC; Kim YS; Kim SJ; Ahn C; Ha J
Ther Drug Monit; 2012 Dec; 34(6):680-5. PubMed ID: 23149441
[TBL] [Abstract][Full Text] [Related]
12. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism.
Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP
Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298
[TBL] [Abstract][Full Text] [Related]
13. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.
Liu LS; Li J; Chen XT; Zhang HX; Fu Q; Wang HY; Xiong YY; Liu S; Liu XM; Li JL; Huang M; Wang CX
Int J Clin Pract Suppl; 2015 May; (183):43-52. PubMed ID: 26177348
[TBL] [Abstract][Full Text] [Related]
15. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
Kang ES; Kim MS; Kim YS; Hur KY; Han SJ; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
Diabetes Care; 2008 Jan; 31(1):63-8. PubMed ID: 17934151
[TBL] [Abstract][Full Text] [Related]
16. Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.
Díaz-Molina B; Tavira B; Lambert JL; Bernardo MJ; Alvarez V; Coto E
Transplant Proc; 2012 Nov; 44(9):2635-8. PubMed ID: 23146479
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus.
Romanowski M; Dziedziejko V; Maciejewska-Karlowska A; Sawczuk M; Safranow K; Domanski L; Pawlik A
Pharmacogenomics; 2015; 16(11):1243-51. PubMed ID: 26282401
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
Choi JY; Kwon OJ
Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
[TBL] [Abstract][Full Text] [Related]
19. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
[TBL] [Abstract][Full Text] [Related]
20. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects.
Lee Sr; Moon JY; Lee SH; Ihm CG; Lee TW; Kim SK; Chung JH; Kang SW; Kim TH; Park SJ; Kim YH; Jeong KH
Kidney Blood Press Res; 2013; 37(2-3):95-102. PubMed ID: 23594830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
